A leading provider of
innovative DNA Screening solutions
13q14.3 Deletion LPH006
From Acute Lymphoblastic Leukaemia to Multiple Myeloma and non-Hodgkin's Lymphoma, deletions in 13q14 are common in B-cell neoplasms. Deletions are observed in 30% of karyotypically normal Multiple Myeloma patients and in over 20% of B-cell Chronic Lymphocytic Leukaemia (CLL) patients. A further 20% have microscopic deletions and 10% exhibit homozygous loss.
13q14.3 Deletion Probe
Cat. No. LPH 006-S (5 tests)
Cat. No. LPH 006 (10 tests)
This webpage could contain information on product details or information not valid in your country or region. Please be aware that we do not take any responsibility for accessing such information, which may not comply with any legal process, regulation, registration or usage in the country of your origin. If you are a resident of a country other than those to which this site is directed, contact your local Cytocell distributor to obtain the appropriate product information for your country of residence.
Developed &produced in the UK